Anteris Technologies says Medtronic will make a strategic investment of up to $90 million in the transcatheter heart valve ...

Anteris Technologies Global (AMEUF) (AVR) announced the pricing of its public offering of 34,782,609 shares at $5.75 per share, to raise about $200 million from this offering, before deductions.  The ...

Medtronic’s investment is contingent on Anteris completing a proposed $200 million public stock offering.

We recently published 10 Stocks Jim Cramer Talked About. Medtronic plc (NYSE:MDT) is one of the stocks on Jim Cramer talked ...

Medtronic plc is rated a Buy with solid growth prospects, balance sheet remains A-rated and shares are undervalued. Learn ...

While the 2026 J.P. Morgan Healthcare Conference has thus far failed to yield any major M&A deals for the industry, Medtronic believes the time is ripe for buyouts. | While the 2026 J.P. Morgan ...

Medtronic will invest $90M in Anteris Technologies for DurAVR TAVR device development, contingent on a $200M IPO.

The three University of Colorado campuses, including CU Boulder, announced a partnership on Thursday with the global ...

Medtronic (MDT) is back on investors’ radar after recent share price moves, with the stock closing at $98.60 on Tuesday. That ...

Medtronic is expected to announce its fiscal third-quarter earnings next month, and analysts project a single-digit profit ...

Oral advice from Medtronic representatives to physicians during a heart device procedure are not preempted from federal law, an Indiana state appeals court has ruled. Judge Theodore M. Sosin in the ...